Viewing Study NCT00723658


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2025-12-30 @ 1:14 AM
Study NCT ID: NCT00723658
Status: WITHDRAWN
Last Update Posted: 2015-03-06
First Post: 2008-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia
Sponsor: SWOG Cancer Research Network
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module